Scholarlink

Purpose <p>To evaluate the effects of photobiomodulation (PBM) on choriocapillaris (CC) perfusion and drusen volume in patients with intermediate age-related macular degeneration (AMD).</p> Methods <p>In this retrospective pilot study, 30 patients receiving PBM therapy and 30 age-matched controls were analysed. Treatment consisted of 8 sessions over 4 weeks using the EYE-LIGHT® device. Best-corrected visual acuity (BCVA), low luminance visual acuity (LLVA), mean drusen volume (MDV), and CC flow deficit percentage (FD%) were evaluated at baseline and 2-month follow-up.</p> Results <p>The PBM group showed significant improvements in BCVA (Δ +3.2 ± 1.4 letters, <i>p</i> = 0.042), reduction in drusen volume (Δ –0.003 ± 0.001 mm³, <i>p</i> = 0.028), and decrease in choriocapillaris FD% (Δ –3.1 ± 1.4%, <i>p</i> = 0.024), while no significant changes were observed in the control group. Changes in choriocapillaris FD% correlated with BCVA improvement (<i>r</i> = –0.54, <i>p</i> = 0.002) and drusen volume reduction (<i>r</i> = 0.35, <i>p</i> = 0.042).</p> Conclusions <p>PBM therapy induces significant choriocapillaris remodelling in intermediate AMD, associated with functional improvement and drusen volume reduction. These findings suggest a potential therapeutic role of PBM in modulating choroidal perfusion in AMD.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Photobiomodulation-induced choriocapillaris perfusion enhancement and outer retinal remodelling in intermediate age-related macular degeneration: a promising therapeutic approach with short-term results

  • 期刊论文

  • 发表日期：

    2025年4月19日

查看全文
  • Pasquale Viggiano,
  • Giacomo Boscia,
  • Arcangelo Clemente,
  • Mariapia Laterza,
  • Alba Chiara Termite,
  • Maria Grazia Pignataro,
  • Antonio Salvelli,
  • Enrico Borrelli,
  • Michele Reibaldi,
  • Giuseppe Giannaccare,
  • Giovanni Alessio,
  • Francesco Boscia

摘要

Purpose

To evaluate the effects of photobiomodulation (PBM) on choriocapillaris (CC) perfusion and drusen volume in patients with intermediate age-related macular degeneration (AMD).

Methods

In this retrospective pilot study, 30 patients receiving PBM therapy and 30 age-matched controls were analysed. Treatment consisted of 8 sessions over 4 weeks using the EYE-LIGHT® device. Best-corrected visual acuity (BCVA), low luminance visual acuity (LLVA), mean drusen volume (MDV), and CC flow deficit percentage (FD%) were evaluated at baseline and 2-month follow-up.

Results

The PBM group showed significant improvements in BCVA (Δ +3.2 ± 1.4 letters, p = 0.042), reduction in drusen volume (Δ –0.003 ± 0.001 mm³, p = 0.028), and decrease in choriocapillaris FD% (Δ –3.1 ± 1.4%, p = 0.024), while no significant changes were observed in the control group. Changes in choriocapillaris FD% correlated with BCVA improvement (r = –0.54, p = 0.002) and drusen volume reduction (r = 0.35, p = 0.042).

Conclusions

PBM therapy induces significant choriocapillaris remodelling in intermediate AMD, associated with functional improvement and drusen volume reduction. These findings suggest a potential therapeutic role of PBM in modulating choroidal perfusion in AMD.